Stay up to date with our newsletter

Get in touch!

View open positions on our Careers page, or connect with us on Linkedin Twitter Facebook Youtube

Lets start the conversation!

Sign up to our newsletter

Thank you!
We will be in touch shortly.

2020.09.10

Sai Life Sciences expands suite of cellular analysis platforms in Cambridge, MA

Discovery Biology Laboratory in Cambridge, MA, USA

Sai Life Sciences today announced the addition of state-of-the-art cellular analysis platforms at its Discovery Biology facility in Cambridge, Massachusetts, USA.

Coinciding with its first anniversary in Cambridge, the expanded suite of capabilities include the Opera Phenix high content screening platform, FACSCelesta flow cytometer and FACSMelody flow sorter, enabling it to better serve start-up and biotech companies in the region, especially in projects exploring novel biology in oncology, neuroscience and rare diseases.

Over the past year, the lab has delivered a range of projects including genetic and pharmacological target validation studies, reagent validation, and developed a variety of assays for its clients, such as cellular target engagement assays and in vitro biomarker assessments.

Describing their experience of working with Sai Life Sciences, Founder & CEO of Auron Therapeutics, Dr Katherine Yen said, “Not only do they perform carefully executed experiments and deliver the data in a timely manner, their technical expertise contributed to the experimental design and interpretation of the results which enabled us to rapidly generate critical data for our drug discovery programs"

Echoing a similar sentiment, Co-Founder & Director of R&D of Eikonizo Therapeutics, Al Schroeder said, “The Sai team was quick to develop a workplan and kick-off the experiments to address our assay development needs, and their presence in Cambridge really expedited the project. We’ve been very happy with their rigor and speed and we will definitely continue to work with them.”

Located in the heart of the Cambridge/Boston biotech ecosystem, Sai’s 8,500 square feet lab in Kendall Square creates opportunities for local biotechs to have frequent face-to-face collaboration with Sai scientists, and to accelerate the pace of their externalized research by reducing cycle-times. The exploratory focus of the lab allows clients to externalize complex biology projects that necessitate more fluid experimental design with real-time decision making. Complementing the team in Cambridge is a larger biology team in India that works in tandem to present clients an optimal solution in terms of speed, cost and talent.

Speaking about the company’s plans, CEO & Managing Director of Sai Life Sciences, Krishna Kanumuri said, “We are committed to helping our clients successfully advance their internal discovery portfolios and are investing considerable resources to provide world-class service in the Boston area. These new capability additions are just the latest in our strategic growth plan with significant additional capabilities coming soon.”

The Cambridge lab serves as a vital bridge, enabling seamless integration with rest of the company’s service offerings across UK and India, spanning the drug discovery and development continuum including medicinal chemistry, DMPK and toxicology, process chemistry and analytical development, and commercial scale manufacturing.

Share article

News

2021.02.11

Dr. Mahavir Prashad joins Sai Life Sciences

Acknowledged scientific leader and Novartis veteran joins Sai Life Sciences

Sai Life Sciences, one of India’s fastest growing Contract Research, Development & Manufacturing Organizations (CRDMOs), today announced the addition of Dr. Mahavir Prashad, an acknowledged scientific leader and industry veteran, to its scientific leadership team as Vice President of Early Phase Process Development. With over three decades of experience in advanced research and roles of […]
Read more

2021.01.28

Sai Life Sciences announces plans to double headcount and expand capabilities in Manchester

Sai Life Sciences announces plans to double headcount and expand capabilities in Manchester, UK

Sai Life Sciences, one of India’s fastest growing Contract Research, Development & Manufacturing Organizations (CRDMOs), today announced plans to double its headcount and expand its suite of technical capabilities at its Manchester site, a centre of excellence for API process and analytical development serving an expanding list of global clients. Making the announcement, Krishna Kanumuri, […]
Read more

2021.01.20

Sai Life Sciences Eye Care Centre

A gateway to high quality eye care

Over half a million people in the northern region of Hyderabad will now have access to high quality eye care in their neighborhood – thanks to the new ‘Sai Life Sciences Eye Care Centre’, opened in partnership with the LV Prasad Eye Institute. On a balmy winter morning last week, we opened doors to the […]
Read more

2020.12.29

Chitrakaar - Paint your imagination

A call to “Paint your imagination” spurs creativity and camaraderie at Sai’s Bidar facility

When a picture can tell a thousand words, imagine what a hundred can do! Our Bidar facility was recently infused with such a surge of creativity and artistic flair, with over a hundred works of art, created by our own Saimers and their families, on display! Each picture lending a unique expression of myriad emotions. […]
Read more

2020.12.18

Double distinction for Sai Life Sciences at the 2021 ATD Excellence in Practice awards

Double distinction for Sai Life Sciences at the 2021 ATD Excellence in Practice awards

Sai Life Sciences won two awards at the prestigious 2021 Association for Talent Development – Excellence in Practice (ATD-EIP) awards. The company was recognized in categories of ‘Learning Technologies’ and ‘Change Management’ through a blind selection process from entries received worldwide. Globally, the annual ATD-EIP awards are highly regarded in the sphere of Training/ Learning […]
Read more